- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00701480
Safety and Efficacy of Skin Cleanser Contained Roselle Extract in Acne
Randomized Double-Blind Case Control Study of Safety and Efficacy of Skin Cleanser Contained Hibiscus Sabdariffa Extract in Acne Treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Acne is one of the most common skin problems in teenagers and adolescents. Keys pathogenesis of the disease are 1.abnormal hypercornification of pilosebaceous duct,2.excess sebum production, 3.inflammation, 4.the present of Propionibacterium acnes. Treatments often include combination of topical and oral medications according to degree of acne severities. Acne medications can lead to drying and irritation of skin. Proper skin cleansing is important and can improve tolerability and efficacy of acne treatment.
Traditional medicine with longstanding used of herbal ingredients for skin problems and beauty is increasing more popular. Hibiscus sabdariffa L.(Roselle) is used as food, drink and topical formulation for skin infection in Thai traditional medicine. The extract from calyces contained polyphenolic compounds and anthocyanins that showed antioxidant and keratolytic activities. There for skin cleanser with Roselle extract might be benefit to acne by loosen comedone, reduce Propionibacterium acne and prevent keratinocyte injury.
The purposes of this study is to evaluate skin cleanser contained Roselle extract in two aspects ; 1. safety for irritation and allergic effects, 2. efficacy in acne as cleanser alone and as supportive care with others acne therapies.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Mali - Achariyakul, MD.
- Phone Number: 66-02-9269473
- Email: mali1799@hotmail.com
Study Contact Backup
- Name: Narumol - Teeranulak, MD.
- Phone Number: 66-02-9269474
- Email: narumol-the@yahoo.com
Study Locations
-
-
Pathumtanee
-
KlongLaung, Pathumtanee, Thailand, 12120
- Recruiting
- Thammasat University
-
Contact:
- Mali - Achariyakul, MD.
- Phone Number: 66-02-9269473
- Email: mali1799@hotmail.com
-
Contact:
- Narumon Teeranurak, MD.
- Phone Number: 66-02-9269474
-
Sub-Investigator:
- Narumon - Teeranurak, MD.
-
Sub-Investigator:
- Vareeporn - Dispanurat, MD.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 12-45 yrs,both sex
- clinical diagnosis of mild to moderately severe acne vulgaris(grade 1-3)
- have at least 10 facial acne lesions
- not changing any acne treatment during study period
- able to follow up according to protocol
- Written informed consent
Exclusion Criteria:
- pregnant or breast feeding
- severe acne(grade4 or nodulocystic acne)
- treated with isotretinoin orally during the last 3 months
- have other systemic disease or illness
- have allergic history to Roselle
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
skin cleanser contained Hibiscus sabdariffa
|
face washing 2-3 times/day
Other Names:
|
Active Comparator: 2
marketed skin cleanser
|
face washing 2-3 times/day
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
1. Safety evaluation: Patch test 2. Efficacy evaluation: Acne lesions counts/ acne severity grading
Time Frame: 6 weeks
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
1. Safety evaluation: "a." Skin properties by visual and tactile features., "b." Biophysical parameters of skin. 2.Efficacy evaluation: Patient assessments.
Time Frame: 6 weeks
|
6 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mali - Achariyakul, MD., Thammasat University
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MTU-E-1-002/51
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acne
-
ProgenaBiomeRecruitingAcne Vulgaris | Acne | Acne Rosacea | Acne Inversa | Acne Keloidalis | Acne Keloid | Acne Conglobata | Acne Cystic | Acne Pomade | Acne Indurata | Acne Papular | Acne Tropica | Acne Urticata | Acne Fulminans | Acne Follicular | Acne Tropicalis | Acne Detergicans | Acne Iodide | Acne VarioliformisUnited States
-
Technische Universität DresdenUnknown
-
Elorac, Inc.Completed
-
Chulalongkorn UniversityCompletedPost - Adolescence AcneThailand
-
National Yang Ming UniversityTaipei City HospitalUnknown
-
Novartis PharmaceuticalsCompletedInflammatory AcneGermany, United States, Hungary, France, Czechia, Netherlands
-
Seoul National University HospitalCompletedAcne, Photodynamic TherapyKorea, Republic of
-
Cipher Pharmaceuticals Inc.CompletedSevere Nodular AcneUnited States, Canada
-
Ulthera, IncCompleted
-
DarierUnknown
Clinical Trials on skin cleanser contained Hibiscus sabdariffa extract
-
Universidad de GranadaRecruitingNeuromuscular PerformanceSpain
-
University of ReadingCompleted
-
TCI Co., Ltd.Completed
-
IRCCS San RaffaeleCompletedUrinary Incontinence | Pelvic Organ Prolapse | Urinary Tract InfectionItaly